Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic

被引：0

作者：

Liegeon, Geoffroy ^{[1
]}

Kaperak, Christopher ^{[1
]}

Friedman, Eleanor E. ^{[1
]}

Djuricich, Paul ^{[2
]}

Dawdani, Alicia ^{[1
]}

Stafford, Kane ^{[2
]}

Plotkin, Sophie ^{[1
]}

Schmitt, Jessica ^{[1
]}

Hazra, Aniruddha ^{[1
]}

Christopoulos, Katerina A. ^{[3
]}

Schneider, John A. ^{[1
]}

Mcnulty, Moira C. ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Chicago, IL USA

[2] Univ Chicago, Dept Pharm, Chicago, IL USA

[3] Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2025年 / 12卷 / 03期

基金：

美国国家卫生研究院;

关键词：

cabotegravir; injectable; long-acting; people with HIV; rilpivirine; PROGRAM; CARE;

D O I：

10.1093/ofid/ofaf094

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We describe referrals and uptake of long-acting injectable cabotegravir/rilpivirine at an academic clinic in Chicago. In a pharmacy-led model, 118 (18%) people with HIV were referred and 78 (12%) initiated long-acting injectable cabotegravir/rilpivirine from 1 January 2021 to 31 May 2023. Implementation, especially for people with HIV who were not virally suppressed, requires further support for patients, providers, and clinic systems.

引用

页数：7

共 33 条

[21]

Lutz T., 2022, HIV DRUG THERAPY GLA

[22] Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV [J].

Manghani, Priyanka ;

Monroe, Anne ;

Castel, Amanda ;

Kumar, Princy ;

Phunmongkol, Jennifer ;

Denyer, Rachel ;

O'Connor, Lauren .

OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (05)

[23] Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials [J].

Mantsios, Andrea ;

Murray, Miranda ;

Karver, Tahilin S. ;

Davis, Wendy ;

Galai, Noya ;

Kumar, Princy ;

Swindells, Susan ;

Bredeek, U. Fritz ;

Garcia, Rafael Rubio ;

Antela, Antonio ;

Gomis, Santiago Cenoz ;

Bernaldez, Miguel Pascual ;

Czarnogorski, Maggie ;

Hudson, Krischan ;

Walters, Nicki ;

Kerrigan, Deanna .

BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)

[24] Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness [J].

Mehtani, Nicky J. ;

Strough, Alix ;

Strieff, Sarah ;

Zevin, Barry ;

Eveland, Joanna ;

Riley, Elise D. ;

Gandhi, Monica .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (01) :61-67

[25] Social Determinants of Health and Care Outcomes Among People With HIV in the United States [J].

Menza, Timothy W. ;

Hixson, Lindsay K. ;

Lipira, Lauren ;

Drach, Linda .

OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07)

[26] Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan Area [J].

Nguyen, Ngan M. ;

Kavanagh, Rebecca ;

Gozar, Martin ;

Cabral, Danielle ;

Goetz, Holly ;

Cha, Agnes ;

Mcgowan, Joseph P. ;

Pao, Megan L. .

AIDS PATIENT CARE AND STDS, 2024, 38 (03) :115-122

[27] Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection [J].

Orkin, Chloe O. C. ;

Arasteh, Keikawus A. K. ;

Hernandez-Mora, M. Gorgolas M. G. H. M. ;

Pokrovsky, Vadim P. V. ;

Overton, Edgar T. O. E. T. ;

Girard, Pierre-Marie G. P. M. ;

Oka, Shinichi O. S. ;

Walmsley, Sharon W. S. ;

Bettacchi, Chris B. C. ;

Brinson, Cynthia B. C. ;

Philibert, Patrick P. P. ;

Lombaard, Johan L. J. ;

Clair, Marty C. M. ;

Crauwels, Herta C. H. ;

Ford, Susan L. F. S. L. ;

Patel, Parul P. P. ;

Chounta, Vasiliki C. V. ;

D'Amico, Ronald D. R. ;

Vanveggel, Simon V. S. ;

Dorey, David D. D. ;

Cutrell, Amy C. A. ;

Griffith, Sandy G. S. ;

Margolis, David A. M. D. A. ;

Williams, Peter E. W. P. E. ;

Parys, Wim P. W. ;

Smith, Kimberly Y. S. K. Y. ;

Spreen, William R. S. W. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12) :1124-1135

[28] Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study [J].

Overton, Edgar T. ;

Richmond, Gary ;

Rizzardini, Giuliano ;

Jaeger, Hans ;

Orrell, Catherine ;

Nagimova, Firaya ;

Bredeek, Fritz ;

Deltoro, Miguel Garcia ;

Swindells, Susan ;

Andrade-Villanueva, Jaime Federico ;

Wong, Alexander ;

Khuong-Josses, Marie-Aude ;

Van Solingen-Ristea, Rodica ;

van Eygen, Veerle ;

Crauwels, Herta ;

Ford, Susan ;

Talarico, Christine ;

Benn, Paul ;

Wang, Yuanyuan ;

Hudson, Krischan J. ;

Chounta, Vasiliki ;

Cutrell, Amy ;

Patel, Parul ;

Shaefer, Mark ;

Margolis, David A. ;

Smith, Kimberly Y. ;

Vanveggel, Simon ;

Spreen, William .

LANCET, 2020, 396 (10267) :1994-2005

[29]

Rajabiun S, 2008, ETHNIC DIS, V18, P403

[30]

Rana A., 2024, C RETR OPP INF 3 MAR

← 1 2 3 4 →